TP53 and B-cell chronic lymphocytic leukemia: Flavopiridol is also a promising agent in inducing p53-independent apoptosis in Chronic Lymphocytic Leukaemia (CLL) and therefore this has been approved as an orphan drug for treating CLL (Christian et al., 2009; Albert et al., 2014; Mandal et al., 2021).